Market Overview:
The global acyclovir injection market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of herpes zoster and other viral infections, rising demand for generic drugs, and growing awareness about the benefits of acyclovir injection. Based on type, the global acyclovir injection market is segmented into 25mg/ml and 50mg/ml. The 25mg/ml segment is expected to account for a larger share of the market in 2018 owing to its lower price point as compared to 50mg/ml products. However, the 50mg/ml segment is projected to grow at a higher CAGR during the forecast period due to its greater efficacy in treating severe cases of herpes zoster and other viral infections. Based on application, hospitals are estimated to account for a larger share of the global acyclovir injection market in 2018 followed by clinics and recovery centers. Hospitals are increasingly adopting injectable drugs owing their ease-of-use over oral medications and better patient outcomes achieved through their use. Clinics are also projected grow at a healthy rate duringthe forecast period due rising demand from patients with chronic diseases that require regular injections such as diabetes mellitusand rheumatoid arthritis .
Product Definition:
Acyclovir Injection is a drug that is used to treat herpes infections. It can be used to treat outbreaks of the virus, as well as to prevent them from occurring in the first place. Acyclovir Injection is also sometimes used to treat chickenpox and shingles.
25mg/ml:
25mg/ml is used for the treatment of acute viral hepatitis, genitourinary infections, and skin infections. It's also used in combination with other antiviral drugs for the treatment of patients with AIDS. The global market for Accyclovir injection is expected to witness significant growth over the forecast period owing to increasing incidences of viral diseases such as HIV-1 infection, HCV infection & others which are fatal if not treated properly.
50mg/ml:
Acyclovir is an antiviral medication used for the treatment of Herpes Simplex Virus (HSV) infections. It is also used in the treatment of varicella-zoster virus infection, which causes chickenpox and shingles. The drug has a wide range of applications including skin infections, cold sores, genital lesions, and ocular disease complications.
Application Insights:
The global acyclovir injection market is segmented on the basis of application into hospital, clinics and recovery centers. The hospital segment dominated the market in 2017 due to high usage rates for various indications such as chickenpox, shingles, varicella zoster infection, influenza infections and cytomegalovirus. In addition to this factor; increasing awareness about acyclovir injections among healthcare professionals is expected to drive demand over the forecast period.
Recovery center was the fastest growing application of acyclovir with an estimated CAGR of XX% from 2018 to 2030 owing to its rising use in treating cold sores and herpetic whitlow amongst others by cauterizing or burning sensation treatment methodologies.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of acyclovir manufacturer coupled with high healthcare expenditure and favorable reimbursement policies. The U.S., which is one of the leading markets for this medication, has an established healthcare infrastructure along with high patient awareness levels regarding Herpes Simplex Virus (HSV) infection and its treatment options.
Asia Pacific is expected to witness lucrative growth over the forecast period due to increasing government initiatives for controlling infectious diseases such as Herpes Simplex Virus (HSV). In addition, rising incidence rates of HIV/AIDS are anticipated to boost demand for acyclovir tablets in this region. Moreover, growing medical tourism industry will also contribute towards market growth over the forecast period.
Growth Factors:
- Increasing incidence of herpes zoster: The increasing incidence of herpes zoster is a major growth driver for the Acyclovir Injection market. According to a study by the Centers for Disease Control and Prevention (CDC), around 1 million people in the U.S. are affected by herpes zoster every year, and this number is expected to rise in the coming years due to population aging. This will create demand for Acyclovir Injection products and drive market growth.
- Rising prevalence of HIV/AIDS: The rising prevalence of HIV/AIDS is another key factor driving market growth, as HIV patients are more susceptible to developing complications such as shingles, which can be treated with Acyclovir Injection products.
- Growing awareness about shingles: There has been an increase in awareness about shingles in recent years, due to campaigns by organizations such as the CDC and Shingles Foundation UK Ltd., which has helped boost demand for Acyclovir Injection products among consumers worldwide..
Scope Of The Report
Report Attributes
Report Details
Report Title
Acyclovir Injection Market Research Report
By Type
25mg/ml, 50mg/ml
By Application
Hospital, Clinics, Recovery Center
By Companies
Pfizer, GSK, AuroMedics, Fresenius Kabi, Fantabulous Pharma, Cipla, Hikma, Square Pharmaceuticals, Shandong Qidu Yaoye, Sichuan Kelun
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
171
Number of Tables & Figures
120
Customization Available
Yes, the report can be customized as per your need.
Global Acyclovir Injection Market Report Segments:
The global Acyclovir Injection market is segmented on the basis of:
Types
25mg/ml, 50mg/ml
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinics, Recovery Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- GSK
- AuroMedics
- Fresenius Kabi
- Fantabulous Pharma
- Cipla
- Hikma
- Square Pharmaceuticals
- Shandong Qidu Yaoye
- Sichuan Kelun
Highlights of The Acyclovir Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 25mg/ml
- 50mg/ml
- By Application:
- Hospital
- Clinics
- Recovery Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Acyclovir Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Acyclovir is an antiviral medication used to treat infections caused by viruses, such as the common cold and flu. It is available in a variety of forms, including tablets and injections. Acyclovir injection is a prescription drug that comes in a liquid form and must be injected into the muscle or vein.
Some of the major players in the acyclovir injection market are Pfizer, GSK, AuroMedics, Fresenius Kabi, Fantabulous Pharma, Cipla, Hikma, Square Pharmaceuticals, Shandong Qidu Yaoye, Sichuan Kelun.
The acyclovir injection market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Acyclovir Injection Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Acyclovir Injection Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Acyclovir Injection Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Acyclovir Injection Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Acyclovir Injection Market Size & Forecast, 2020-2028
4.5.1 Acyclovir Injection Market Size and Y-o-Y Growth
4.5.2 Acyclovir Injection Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 25mg/ml
5.2.2 50mg/ml
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinics
6.2.3 Recovery Center
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Acyclovir Injection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Acyclovir Injection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 25mg/ml
9.6.2 50mg/ml
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinics
9.10.3 Recovery Center
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 25mg/ml
10.6.2 50mg/ml
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinics
10.10.3 Recovery Center
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 25mg/ml
11.6.2 50mg/ml
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinics
11.10.3 Recovery Center
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 25mg/ml
12.6.2 50mg/ml
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinics
12.10.3 Recovery Center
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 25mg/ml
13.6.2 50mg/ml
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinics
13.10.3 Recovery Center
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Acyclovir Injection Market: Competitive Dashboard
14.2 Global Acyclovir Injection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 GSK
14.3.3 AuroMedics
14.3.4 Fresenius Kabi
14.3.5 Fantabulous Pharma
14.3.6 Cipla
14.3.7 Hikma
14.3.8 Square Pharmaceuticals
14.3.9 Shandong Qidu Yaoye
14.3.10 Sichuan Kelun
